Published in Women's Health Weekly, January 22nd, 2000
The 2 specific treatment changes were an increase in the use of highly purified forms of gonadotropins and a decreased use of GnRH agonists in short-course regimens.
Daniel W. Cramer, MD, ScD, from the Ob-Gyn Epidemiology Center at Brigham and Women's Hospital in Boston, Massachusetts, and colleagues from the Boston area examined detailed treatment-related information and outcomes on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly